2 Green Flags for Vertex Pharmaceuticals' Future

Biotech Vertex Pharmaceuticals (NASDAQ: VRTX) is defying the stock market sell-off this year. The drugmaker's shares are up by an impressive 22% year to date. While that's great news for shareholders, it's essential to look beyond a mere six months' worth of stock market performances.

Those in it for the long haul will want to know whether Vertex is likely to keep up this pace. Fortunately, there are good reasons to think the biotech has what it takes to continue beating the market. Let's look at two of these reasons.

Continue reading

Source Fool.com